http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6806077-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99505f5f312672820e9f78c254c00a4d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2828
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
filingDate 1998-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5bbc1b5e4df0f4797cf69b5e2a11783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45570423023e7436da93280b8ee99a73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c5269c2853bd0d980214c833127ac8e
publicationDate 2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6806077-B1
titleOfInvention Method for screening substances with therapeutic action in the treatment of transmissable subacute spongiform encephalopathies
abstract The invention concerns a method for screening substances capable of having therapeutic action in the treatment of transmissible subacute spongiform encephalopathy (TSSE) or prion diseases comprising a step of isolating the PrPres, from the spleen, methods for isolating the PrPres, particularly adapted to said screening method and their applications, in particular for detecting PrPres.
priorityDate 1997-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9323432-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5834593-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5276059-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129773695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135802183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20112203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226573393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46783367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50990393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442828

Total number of triples: 40.